创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

口服自微乳给药系统的研究进展

Research Progress of Oral Self-Microemulsifying Drug Delivery System

  • 摘要: 自微乳给药系统能够显著提高水难溶性药物的口服生物利用度,且最终的给药形式多样,在推进高生物利用度口服递药系统的发展中,表现出良好的应用前景。但自微乳给药系统也存在诸如存储运输不便、稳定性不佳、体外释药评价局限等问题。随着近年来新型载体材料和制剂技术的发展,对固体自微乳给药系统、过饱和自微乳给药系统等新型制剂的研究日益增多,在弥补传统自微乳给药系统不足的同时,可发挥自微乳给药系统的优势。综述自微乳给药系统的辅料组成、促进药物口服吸收的机制、固化方法及体外释药评价方法的研究进展。

     

    Abstract: Self-microemulsifying drug delivery system (SMEDDS) can significantly improve the oral bioavailability of water-insoluble drugs with diversified forms of administration, which has shown great application prospects in promoting the development of oral drug delivery system with high bioavailability. There are still some problems in SMEDDS such as inconvenience of storage and transportation, poor stability, and limitations of drug release evaluation. Recently, with the development of new materials and new technology in drug preparation, there have been an increasing number of researches on new pharmaceutical preparations such as solid self-microemulsifying delivery system and supersaturated self-microemulsifying delivery system, which can make up the deficiency of traditional SMEDDS and make use of its advantages. This paper reviews the excipients composition, oral absorption mechanism, solidification methods and release evaluation methods of SMEDDS.

     

/

返回文章
返回